Back
 Health  Vol.8 No.4 , February 2016
Application of Precision-Cut Rat Liver Slice to Study the Influence of Monocrotaline, Tussilago farfara Alkaloids on the Expression of Cytochrome P450 Enzymes
Abstract: Precision-cut liver slice has been successfully used to study the mechanism of drug-induced hepatotoxicity, the prediction of liver toxicity, the discovery of early hepatic toxicity biomarker and the metabolism of drug in liver. We detected the expression of CYP3A4, CYP2B1 + CYP2B2 and CYP2E1 in precision-cut liver slice after co-cultured with monocrotaline or Tussilago farfara alkaloids to investigate the hepatotoxicity mechanism of those drugs. After co-culturing with monocrotaline or Tussilago farfara alkaloids for 6 hours, the expression of CYP3A4 in the microsome of precision-cut liver slices was detected by Western blot, and the expressions of CYP2B1 + CYP2B2 and CYP2E1 were detected by immunofluorescence. The results showed that monocrotaline induced the expression of CYP3A4 and CYP2B1 + CYP2B2, and Tussilago farfara alkaloids obviously up-regulated the expression of CYP2E1 and CYP3A4. Thus, we conclude that the up-regulation of CYP3A4, CYP2B1 + CYP2B2 and CYP2E1 may be one of the toxic mechanisms of liver injury of those drugs.
Cite this paper: Wang, H. , Hui, L. , Li, C. , Liu, T. , Yu, C. , Cao, C. , Hao, R. and Zhang, Y. (2016) Application of Precision-Cut Rat Liver Slice to Study the Influence of Monocrotaline, Tussilago farfara Alkaloids on the Expression of Cytochrome P450 Enzymes. Health, 8, 370-379. doi: 10.4236/health.2016.84039.
References

[1]   Catania, J.R., McGarrigle, B.P., Rittenhouse-Olson, K. and Olson, J.R. (2007) Induction of CYP2B and CYP2E1 in Precision-Cut Rat Liver Slices Cultured in Defined Medium. Toxicology in Vitro, 21, 109-115.
http://dx.doi.org/10.1016/j.tiv.2006.08.001

[2]   Neyrinck, A.M., Gomez, C. and Delzenne, N.M. (2004) Precision-Cut Liver Slices in Culture as a Tool to Assess the Physiological Involvement of Kupffer Cells in Hepatic Metabolism. Comparative Hepatology, 3, S45.
http://dx.doi.org/10.1186/1476-5926-2-S1-S45

[3]   Lake, B.G., Charzat, C., Tredger, J.M, . Renwick, A.B., Beamand, J.A. and Price, R.J. (1996) Induction of Cytochrome P450 Isoenzymes in Cultured Precision-Cut Rat and Human Liver Slices. Xenobiotica, 26, 297-306.
http://dx.doi.org/10.3109/00498259609046709

[4]   Lerche-Langrand, C. and Toutain, H.J. (2000) Precision-Cut Liver Slices: Characteristics and Use for in Vitro Pharmaco-Toxicology. Toxicology, 153, 221-253.
http://dx.doi.org/10.3109/00498259609046709

[5]   Lupp, A., Danz, M. and Müller, D. (2001) Morphology and Cytochrome P450 Isoforms Expression in Precision-Cut Rat Liver Slices. Toxicology, 161, 53-66.
http://dx.doi.org/10.1016/S0300-483X(01)00333-X

[6]   Krumdieck, C.L., dos Santos, J.E. and Ho, K.J. (1980) A New Instrument for the Rapid Preparation of Tissue Slices. Analytical Biochemistry, 104, 118-123.
http://dx.doi.org/10.1016/0003-2697(80)90284-5

[7]   Behrsing, H.P., Vickers, A.E. and Tyson, C.A. (2003) Extended Rat Liver Slice Survival and Stability Monitored Using Clinical Biomarkers. Biochemical and Biophysical Research Communications, 312, 209-213.
http://dx.doi.org/10.1016/0003-2697(80)90284-5

[8]   van Midwoud, P.M., Groothuis, G.M., Merema, M.T. and Verpoorte, E. (2010) Microfluidic Biochip for the Perifusion of Precision-Cut Rat Liver Slices for Metabolism and Toxicology Studies. Biotechnology and Bioengineering, 105, 184-194.
http://dx.doi.org/10.1002/bit.22516

[9]   de Graaf, I.A., Olinga, P., de Jager, M.H., Merema, M.T., de Kanter, R., van de Kerkhof, E.G. and Groothuis, G.M. (2010) Preparation and Incubation of Precision-Cut Liver and Intestinal Slices for Application in Drug Metabolism and Toxicity Studies. Nature Protocols, 5, 1540-1551.
http://dx.doi.org/10.1002/bit.22516

[10]   Geng, X.C., Shen, L.Z., Li, B. and Wang, J.Z. (2011) Progress of Biomarkers for Hepatic Toxicity. Chinese Pharmaceutical Journal, 46, 721-725.

[11]   Wang, J., Wang, C.H. and Wang, Z.T. (2007) Advancement of Investigation on Cytotoxicity and Mechanism of Pyrrolizidine Alkaloids. International Journal of Pharmaceutical Research, 34, 246-249, 258.

[12]   Liu, P. (2004) Liver Injuries Caused by Chinese Herbs. Chinese Journal of Hepatology, 12, 243.

[13]   Zeng, M.Y., Li, M.M. and Zhao, X.W. (1996) Traditional Chinese Medicine Containing Pyrrolizidine Alkaloids and Its Toxicity(2)-Tussilago farfara L. and Petasites japonicas miq.etc. Traditional Chinese Drug Research and Clinical Pharmacology, 7, 51-52.

[14]   Keller, K., Hansel, R., De Smet, P.A.G.M. and Chandler, R.F. (1992) Adverse Effects of Herbal Drugs. Vol. 1, Springer-Verlag, Berlin Heidelberg, 191-206, 211-214.

[15]   Williams, G.M., Mori, H., Hirono, I. and Nagao, M. (1980) Genotoxicity of Pyrrolizidine Alkaloids in the Hepatocyte Primary Culture/DNA-Repair Test. Mutation Research/Genetic Toxicology, 79, 1-5.
http://dx.doi.org/10.1016/0165-1218(80)90141-X

[16]   Müller, L., Kasper, P. and Kaufmann, G. (1992) The Clastogenic Potential in Vitro of Pyrrolizidine Alkaloids Employing Hepatocyte Metabolism. Mutation Research/Genetic Toxicology, 282, 169-176.
http://dx.doi.org/10.1016/0165-7992(92)90091-U

[17]   Wagner, J.G., Petry, T.W. and Roth, R.A. (1993) Characterization of Monocrotalinepyrrole-Induced DNA Cross-Linking in Pulmonary Artery Endothelium. American Journal of Physiology, 264, L517-L522.

[18]   Zhang, G.S. (2003) Cytochrome P450 and Drug Induced Liver Injury. Journal of Jinzhou Medical College, 5, 45-47.

[19]   Kaplowitz, N. (2002) Biochemical and Cellular Mechanisms of Toxic Liver Injury. Seminars in Liver Disease, 22, 137-144.
http://dx.doi.org/10.1055/s-2002-30100

[20]   Vuilleumier, N., Rossier, M.F. and Chiappe, A. (2006) CYP2E1 Genotype Andi-Soniazid-Induced Hepatotoxicity in Patients Treated for Latent Tuber-Culosis. European Journal of Clinical Pharmacology, 62, 423-429.
http://dx.doi.org/10.1007/s00228-006-0111-5

[21]   Wolf, K.K., Wood, S.G., Allard, J.L., Hunt, J.A., Gorman, N., Walton-Strong, B.W., et al. (2007) Role of CYP3A and CYP2E1 in Alcohol-Mediated Increases in Acetaminophen Hepato-Toxicity: Comparison of Wild-Type and Cyp2e1(-/-) Mice. Drug Metabolism and Disposition, 35, 1223-1231.
http://dx.doi.org/10.1124/dmd.107.014738

[22]   Yao, J.-C., Rao, J., Zeng, L.-G., Zhang, L.-Y., Jiang, Z.-Z., He, L., Hu, L. and Zhao, X.-Y. (2010) Metabolism and Enzyme Kinetics of Triptolide in Rat Liver Microsomes. China Pharmacy, 7, 577-580.

[23]   Hui, L.Q., Gao, S.R., Liu, T., Cao, C.Y., Guo, J., Hao, R., Yi, Y., Li, C.Y., Zhao, Y. and Liang, A.H. (2011) Evaluation of Vitro Hepatotoxicity of Monocrotaline by Precision-Cut Liver Slice Technique. China Journal of Chinese Materia Medica, 36, 628-632.

[24]   Hui, L.Q., Gao, S.R., Liu, T., Li, C.Y., Hao, R., Yi, Y., Guo, J., He, R., Cao, C.Y., Zhao, Y., Liang, A.H. and Zhang, Y. (2012) Hepatotoxicity on Water Extracts and the Total Alkaloid of Farfarae Flos. Chinese Journal of Experimental Traditional Medical Formulae, 18, 238-241.

[25]   Pu, S.B., Xu, D.R., Zhang, M., Zhou, H.H., Wang, Z.T. and Yu, G.D. (2004) The Detection of Hepatotoxic Pyrrolizidine Alkaloids in Flos Farfarae by LC/MSn. Chinese Journal of Natural Medicines, 2, 293-297.

[26]   Pessayre, D. (1995) Role of Reactive Metabolites in Drug-Induced Hepatitis. Journal of Hepatology, 23, 16-24.

[27]   Ma, K.F., Xie, X.J., Liu, Y. and Jia, H.Y. (2013) Progress in Genetic Polymorphism of Cytochrome P450 Enzymes and Drug-Induced Liver Injury. Chinese Journal of Pharmacology and Toxicology, 27, 889-892.

[28]   Bozina, N., Bradamante, V. and Lovric, M. (2009) Genetic Polymorghism of Metabolic Enzymes P450(CYP) as a Susceptibility Factor for Drug Response, Toxicity, and Cancer Risk. Archives of Industrial Hygiene and Toxicology, 60, 217-242.
http://dx.doi.org/10.2478/10004-1254-60-2009-1885

[29]   Yan, M.F., Hao, F.R., Xu, L.M., Tong, S.G., Ji, H.J., Shen, Z.F. and Jin, Y.Z. (2005) Effects of Mitomycin(MMC) and γ-Ray Irradiation on Cytochome p450 Content and Activities of CYP2B1 and CYP2E1 in Rats. Journal of Radiation Research and Radiation Processing, 23, 246-250.

[30]   Graaf, I.A., Groothuis, G.M. and Olinga, P. (2007) Precision-Cut Tissue Slices as a Tool to Predict Metabolism of Novel Drugs. Expert Opinion on Drug Metabolism & Toxicology, 3, 879-898.
http://dx.doi.org/10.1517/17425255.3.6.879

[31]   Olinga, P., Groen, K., Hof, I.H., De Kanter, R., Koster, H.J., Leeman, W.R., Rutten, A.A., Van Twillert, K. and Groothuis, G.M. (1997) Comparison of Five Incubation Systems for Rat Liver Slices Using Functional and Viability Parameters. Journal of Pharmacological and Toxicological Methods, 38, 59-69.
http://dx.doi.org/10.1016/s1056-8719(97)00060-9

[32]   Vanden Branden, M., Wrighton, S.A., Ekins, S., Gillespie, J.S., Binkley, S.N., Ring, B.J., Gadberry, M.G., Mullins, D.C., Strom, S.C. and Jensen, C.B. (1998) Alterations of the Catalytic Activities of Drug-Metabolizing Enzymes in Cultures of Human Liver Slices. Drug Metabolism and Disposition, 26, 1063-1068.

[33]   Xu, L.M. (2005) Understanding and Prevention of Liver Damage Caused by Chinese Herbal Medicine. Journal of Modern Medicine & Health, 21, 379-380.

 
 
Top